Among ccRCC samples, several genes demonstrated statistically significant differential expression between treatment groups (LRRC75A, TMEM154, TALAM1, C1orf56, SYNC, ITPR1, CYP1B1, KCNA5, MIR23AHG, and FANCA; Figure 1C). This evidence concerns the gene CYP1B1 and nonpapillary renal cell carcinoma.